Assessment of Biochemical measurements with vitamin D deficiency in nephrotic syndrome patient

Authors

  • Imran Mangi Sindh Institute of Urology Transplantation, SIUT, Karachi. Pakistan
  • Dr Sajid Saad Sindh Institute of Urology Transplantation, SIUT, Karachi. Pakistan
  • Dr Ranjeet Kumar Sindh Institute of Urology Transplantation, SIUT, Karachi. Pakistan

DOI:

https://doi.org/10.53778/pjkd81247

Keywords:

Nephrotic syndrome, vitamin D, deficiency, calcium, hypoalbuminemia, bone mineral metabolism

Abstract

OBJECTIVE: To determine the frequency of vitamin D deficiency and bone mineral metabolism abnormalities in patients with nephrotic syndrome.

PATIENTS AND METHODS: Between June to December 2019, all patients who fulfilled the inclusion criteria and visited to SIUT, Karachi were included in the study, which is a descriptive cross sectional study. Informed consent was taken after explaining the procedure, risks and benefits of the study. Blood samples of all the patients were taken for measurement of vitamin D and bone mineral metabolism abnormalities.

RESULTS: Out of 92 patients, 51(55.4%) were male while 41 (44.6%) were female Mean ± SD of age was 32.76±10.16 years. Vitamin D deficiency was found in 49 (53.3%) patients. Hypocalcemia occurred in 48 (52.2%) patients. Raised Alkaline phosphate was found in 42 (45.7%) patients.

CONCLUSION: It is to be concluded that vitamin D deficiency and bone mineral metabolism abnormalities were documented in considerable number of patients presenting with nephrotic syndrome.

References

Geme JW, Schor NF, Behrman RE. Nelson textbook of pediatrics. Elsevier Health

Sciences; 2016.

Esmaeeili M, Azarfar A, Hoseinalizadeh S. Calcium and vitamin D metabolism in pediatric

nephrotic syndrome; an update on the existing literature. Int J Pediatr. 2015;3(2):103-9.

Banerjee S, Basu S, Sengupta J. Vitamin D in nephrotic syndrome remission: a case

control study. Pediatr, Nephrol. 2013;28(10):1983-9.

Subandiyah K, Khanifa H, Kardani AK. Effect of corticosteroid and vitamin D3 as

combined therapy on 25 (OH) vitamin D serum level and regulatory T (TReg) cells

population in children with idiopathic nephrotic syndrome. Bali Med J. 2018;7(3):639

Powe CE, Ricciardi C, Berg AH. Vitamin D-binding protein modifies the vitamin D-bone

mineral density relationship. J Bone Min Res. 2011;26(7):1609-16.

Nielsen CA, Jensen JE, Cortes D. Vitamin D status is insufficient in the majority of

children at diagnosis of nephrotic syndrome. Dan Med J. 2015;62(2):A5017.

Selewski DT, Chen A, Shatat IF, Pais P, Greenbaum LA, Geier P, et al. Vitamin D in

incident nephrotic syndrome: a Midwest Pediatric Nephrology Consortium study.

Pediatr Nephrol. 2016;31(3):465-72.

Sheikh A, Saeed Z, Jafri SA, Yazdani I, Hussain SA. Vitamin D levels in asymptomatic

adults-a population survey in Karachi, Pakistan. Plos One. 2012;7(3):e33452.

Solanki JR, Sudhakaran S, Shringarpure KS. Prevalence of Vitamin D3 deficiency among

pediatric patients with idiopathic nephrotic syndrome in remission: a cross-sectional

observational study from Vadodara, Gujarat. Indian Child Health. 2018;5(7):481-3.

Yadav VK, Sharma S, Debata PK, Patel S, Kabi BC, Aggrawal KC. Change in bone mineral

density and role of Vitamin D and calcium supplementation during treatment of first

episode nephrotic syndrome. J Clin Diagn Res. 2017;11(9):SC18.

Khan AH, Iqbal R, Naureen G, Dar FJ, Ahmed FN. Prevalence of vitamin D deficiency and

its correlates: results of a community-based study conducted in Karachi, Pakistan. Arch

Osteoporos. 2012;7(1–2):275–82.

Iqbal R, Jafri L, Haroon A, Habib A. Illuminating the dark side-vitamin D status in

different localities of Karachi. J Coll Physicians Surg Pak. 2013;23(8):604-6.

Korkor A, Schwartz J, Bergfeld M, Teitelbaum S, Teitelbaum L, Klahr S, et al. Absence of

metabolic bone disease in adult patients with the nephrotic syndrome and normal renal

function. J Clin Endocrinol Metab. 1983;56(3):496-500.

Goldstein DA, Oda Y, Kurokawa K, Massry SG. Blood levels of 25-hydroxy vitamin D in

nephrotic syndrome. Studies in 26 patients. Ann Intern Med. 1977;87(6):664–7.

Shivanand I, Velagala SV, Sudhindrashayana RF. Study of prevalence of vitamin D

deficiency in nephrotic syndrome. Int J Contemp Pediatr. 2019;6(2).

Aggarwal A, Yadav AK, Ramachandran R, Kumar V, Kumar V, Sachdeva N, et al.

Bioavailable vitamin D levels are reduced and correlate with bone mineral density and

markers of mineral metabolism in adults with nephrotic syndrome. Nephrol.

;21(6):483-9.

Meguid El Nahas A, Bello AK. Chronic kidney disease: the global challenge. Lancet

;365:331–40.

Moe S, Drueke T, Cunningham J, Goodman W, Martin K, Olgaard K, et al. Definition,

evaluation, and classification of renal osteodystrophy: a position statement from Kidney

Disease: Improving Global Outcomes (KDIGO). Kidney Int 2006;69:1945–53.

Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, et al. Prevalence of

abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic

kidney disease: results of the study to evaluate early kidney disease. Kidney Int 2007;71:

–8.

Al Zahrani A, Levine MA. Primary hyperparathyroidism. Lancet. 1997;349:1233-8.

Malluche HH, Goldstein DA, Massry SG. Osteomalacia and hyperparathyroid bone

disease in patients with nephrotic syndrome. J Gun Invest 1979;63:494-500

Goldstein DA, Oda Y, Kurokawa K, Massry SO. Blood level of 25-hydroxyvitamin-D in

nephrotic syndrome. Ann Intern Med 1977;87:664-7.

Tessitore N, BoNucci E, D'Angelo A, Lund B, Corgnati A, Lund B, et al. Bone histology and

calcium metabolism in patients with nephrotic syndrome and normal or reduced renal

function. Nephron 1984;37:153-9.

Freundlich M, Bourgoignie JJ, Zilleruelo G, Jacob Al, Canterbury JM, Strauss J. Bone

modulating factors in nephrotic children with normal glomerular filtration rate.

Pediatrics 1985;76:280-5.

Alon U, Chan JCM. Calcium and vitamin-D metabolism in nephrotic syndrome. J Pediatr

Nephrol 1983;4:115-8.

Nelson W, Kliegman R. Nelson Textbook of Pediatrics. Philadelphia, PA: Elsevier; 2016.

Goldstein DA, Haldimann B, Sherman D, Norman AW, Massry SG. Vitamin D metabolites

and calcium metabolism in patients with nephrotic syndrome and normal renal function.

J Clin Endocrinol Metabol. 1981;52(1):116-21.

Bak M, Serdaroglu E, Guclu R. Prophylactic calcium and vitamin D treatments in steroid treated children with Nephrotic syndrome. Pediatr Nephrol. 2006;21:350-4.

Kinra S, Rath B, kabi B. Indirect quantification of lipid peroxidation in steroid responsive

nephrotic syndrome. Arch Dis Child. 2000;82:76-8.

Elsevier Clinical Advisory Board, Clinical Update: Nephrotic Syndrome. 2012.

Cunnane G, Lane NE. Steroid induced osteoporosis in systemic lupus erythematosus.

Rheum Dis North Am 2000;26:311-29.

Pitt P, Todd P, Webber D, Pack S, Moniz C. A double blind placebo controlled study to

determine the effects of intermittent cyclical etidronate on bone mineral density in

patients on long term oral corticosteroid treatment. Thorax 1998;53:351-6.

Sambrook PN. Inhaled corticosteroids, bone density and risk of fracture. Lancet

;355:9213.

Joshi U, Subedi R, Poudel P, Ghimire PR, Panta S, Sigdel MR. Assessment of quality of life

in patients undergoing hemodialysis using WHOQOL BREF questionnaire: a multicenter

study. Int J Nephrol Renovasc Dis. 2017;10:195-203.

Chauhan R, Mendonca S. Adequacy of twice weekly hemodialysis in end stage renal

disease patients at a tertiary care dialysis centre. Indian J Nephrol. 2015;25(6):329.

Cetin N, Gencler A, Sivrikoz IA. Bone mineral density and vitamin D status in children

with remission phase of steroid-sensitive nephrotic syndrome. Saudi J Kidney Dis

Transpl. 2019;30(4):853.

Bhan I, Dobens D, Tamez H, Deferio JJ, Li YC, Warren HS, et al. Nutritional vitamin D

supplementation in dialysis: a randomized trial. Clin J Am Soc Nephrol. 2015;10(4):611-

Erdem E. Proton pump inhibitors use in hemodialysis patients and serum magnesium

levels. Int J Clin Exp Med. 2015;8(11):21689.

Bansal B, Bansal S, Mithal A, Kher V, Marwaha R. Vitamin D deficiency in hemodialysis

patients. Indian J Endocrinol Metab. 2012;16(2):270.

Marquardt P, Krause R, Schaller M, Bach D, von Gersdorff G. Vitamin D status and cancer

prevalence of hemodialysis patients in germany Anticancer Res. 2015;35(2):1181-87.

Frost M, Abrahamsen B, Nielsen TL, Hagen C, Andersen M, Brixen K. Vitamin D status

and PTH in young men: A cross-sectional study on associations with bone mineral

density, body composition and glucose metabolism. Clin Endocrinol (Oxf) 2010;73:573-

Downloads

Published

2024-03-31